Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirvaso in rosacea erythema
NCT02249065Phase 4Completed
- Sponsor
- Galderma
- Start
- Sep 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in rosacea, sponsored by Galderma. Started Sep 2014; status: completed.
02
Drugs
brimonidine
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT02249065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249065.